C
Carlo Gennari
Researcher at University of Siena
Publications - 242
Citations - 10616
Carlo Gennari is an academic researcher from University of Siena. The author has contributed to research in topics: Osteoporosis & Bone remodeling. The author has an hindex of 52, co-authored 242 publications receiving 10380 citations. Previous affiliations of Carlo Gennari include Washington University in St. Louis.
Papers
More filters
Journal ArticleDOI
Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis
Harry K. Genant,Colin Cooper,Gyula Poór,Ian R. Reid,George E. Ehrlich,John A. Kanis,B E Nordin,Elizabeth Barrett-Connor,Dennis Black,Jean-Philippe Bonjour,Bess Dawson-Hughes,Pierre D. Delmas,J. Dequeker,S Ragi Eis,Carlo Gennari,Olof Johnell,C. Conrad Johnston,Edith M. C. Lau,Uri A. Liberman,Robert Lindsay,T. J. Martin,B. Masri,Carlos Mautalen,P. J. Meunier,Nikolai Khaltaev +24 more
TL;DR: Harry K. Genant (Chairman) , Cyrus Cooper (Rapporteur) , Gyula Poor (Rappy) , Ian Reid (R apporteur), George Ehrlich (Editor) and Nikolai Khaltaev (WHO Secretariat) 30
Journal ArticleDOI
Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study.
Olof Johnell,Bo Gullberg,John A. Kanis,Erik Allander,L. Elffors,Jan Dequeker,Guzin Dilsen,Carlo Gennari,Lopes Antonio Vaz,George P. Lyritis,Gianfranco Mazzuoli,L. Miravet,Mario Passeri,Perez Ramon Cano,Aurelio Rapado,Claude Ribot +15 more
TL;DR: Variations in lifestyle factors are associated with significant differences in the risk of hip fracture, account for a large component of the total risk, and may be of some value in selecting individuals at high risk.
Journal ArticleDOI
Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial
Pierre D. Delmas,Kristine E. Ensrud,Jonathan D. Adachi,Kristine D. Harper,S Sarkar,Carlo Gennari,Jean-Yves Reginster,Huibert A.P. Pols,Robert R. Recker,Steven T. Harris,W Wu,Harry K. Genant,Dennis M. Black,Richard Eastell +13 more
TL;DR: Raloxifene 60 and 120 mg/d through 4 yr decreased the cumulative risk of new vertebral fractures in postmenopausal women with osteoporosis.
Journal ArticleDOI
Risk Factors for Hip Fracture in Men from Southern Europe: The MEDOS Study
J. A. Kanis,Olof Johnell,Bo Gullberg,Erik Allander,L. Elffors,Jonas Ranstam,J. Dequeker,Güzin Dilşen,Carlo Gennari,A. Lopes Vaz,George P. Lyritis,Gianfranco Mazzuoli,L. Miravet,Mario Passeri,R. Pérez Cano,A. Rapado,Claude Ribot +16 more
TL;DR: It is concluded that lifestyle factors are associated with significant differences in the risk of hip fracture and potentially remediable factors including a low degree of physical exercise and a low BMI account for a large component of the total risk.
Journal ArticleDOI
Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
TL;DR: Assessment of bone turnover cannot help predict the severity of bone loss in post menopause; calcitonin therapy appears to be particularly indicated for patients with high-turnover osteoporosis, resulting in a net gain of bone mineral in the axial skeleton and a slowing of bone Loss in the appendicular bones.